Close Menu

NEW YORK (GenomeWeb) — Genomic sequencing business incubator Murrieta Genomics has agreed to promote SeqOnce Biosciences' next-generation sequencing sample prep technology, the companies announced today.

SeqOnce was founded in 2014 as a spinout of the University of Southern California and has developed a technology called RhinoSeq for NGS library preparation that the Pasadena-based company says is significantly quicker than competing methods.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers in India plan to sequence SARS-CoV-2 isolates from around the country, according to LiveMint.

Mauro Ferrari has resigned as president of the European Research Council over its response to the COVID-19 pandemic, the Financial Times reports.

Stat News reports some health tech startups are laying off or furloughing workers.

In Genome Research this week: indels affecting microsatellites in cancer, analytical approach to find key regulatory elements, and more.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

May
19
Sponsored by
10x Genomics

Uveal melanoma (UM) is a highly metastatic cancer that, in contrast to cutaneous melanoma, is largely unresponsive to checkpoint immunotherapy.